↓ Skip to main content

Dove Medical Press

Article Metrics

Pneumonia immunization in older adults: review of vaccine effectiveness and strategies

Overview of attention for article published in Clinical Interventions in Aging, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
9 tweeters

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
77 Mendeley
Title
Pneumonia immunization in older adults: review of vaccine effectiveness and strategies
Published in
Clinical Interventions in Aging, November 2012
DOI 10.2147/cia.s29675
Pubmed ID
Authors

Ali El-Solh, Assaad, El-Masri, Jahan Porhomayon

Abstract

Vaccination remains the primary preventive strategy in the elderly against Streptococcus pneumoniae and influenza infections. The effectiveness of this strategy in preventing pneumonia has been in doubt despite the increase in vaccination coverage among older adults. Randomized controlled trials (RCTs) and observational studies aimed at determining clinical outcomes and immune response following pneumococcal vaccination have yielded conflicting results. The protective efficacy of pneumococcal vaccination against pneumonia in older adults has not been firmly established due to a lack of RCTs specifically examining patients ≥ 65 years of age. Similarly, the reported benefits of influenza vaccination have been derived from observational data. The assessment of clinical benefit from influenza vaccination in the elderly population is complicated by varying cohorts, virulence of the influenza strain, and matching of vaccine and circulating viral strains. The presence of selection bias and use of nonspecific end points in these studies make the current evidence inconclusive in terms of overall benefit. The development of more immunogenic vaccines through new formulations or addition of adjuvants holds the promise of revolutionizing delivery and improving efficacy. Dismantling existing barriers through education, providing technology assistance predominantly to developing countries, and establishing clear regulatory guidance on pathways for approval are necessary to ensure timely production and equitable distribution.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 3%
Unknown 75 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 25%
Researcher 13 17%
Student > Ph. D. Student 9 12%
Student > Doctoral Student 8 10%
Student > Postgraduate 7 9%
Other 21 27%
Readers by discipline Count As %
Medicine and Dentistry 39 51%
Agricultural and Biological Sciences 13 17%
Unspecified 6 8%
Biochemistry, Genetics and Molecular Biology 4 5%
Nursing and Health Professions 4 5%
Other 11 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2016.
All research outputs
#3,063,370
of 12,384,042 outputs
Outputs from Clinical Interventions in Aging
#359
of 1,271 outputs
Outputs of similar age
#31,326
of 138,986 outputs
Outputs of similar age from Clinical Interventions in Aging
#6
of 19 outputs
Altmetric has tracked 12,384,042 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 138,986 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.